Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Clinical profile of patients with heart failure can predict rehospitalization and quality of life

View through CrossRef
Background The aim of this retrospective study was to identify clinical, humoral and echocardiographic variables predicting rehospitalization and poor quality of life (QOL) in patients with reduced or mid-range ejection fraction heart failure. Methods From 2009 to 2012, 310 patients were admitted having signs and symptoms of heart failure with reduced ejection fraction. All the patients were followed by phone, calling the patients or the referring general practitioner. The Minnesota Living with Heart Failure Questionnaire (MLHFQ) was used as the instrument to evaluate QOL: MLHFQ less than 24 is a good QOL, 24–45 is moderate QOL and more than 45 is poor QOL. The primary event was poor QOL and/or rehospitalization at 4 years. Results Seventy-nine patients died at median time of 21 months; 4-year survival was 72 ± 3%. Rehospitalization due to heart failure was recorded in 60 cases. Among 231 survivors, MLHFQ score was good in 99 (42%), moderate in 50 (21%) and poor in 88 (37%). Four-year freedom from death, poor QOL or rehospitalization was 51 ± 3%. Multivariable analysis identified the following risk factors: heart rate at discharge at least 70 bpm, ischemic heart disease, atrial fibrillation, hypercholesterolemia, chronic pulmonary disease, N-terminal pro brain natriuretic peptide at discharge, severe tricuspid regurgitation and mitral regurgitation more than moderate. Conclusion Clinical, laboratory and echocardiographic profile is crucial to predict long-term QOL of patients admitted for heart failure.
Title: Clinical profile of patients with heart failure can predict rehospitalization and quality of life
Description:
Background The aim of this retrospective study was to identify clinical, humoral and echocardiographic variables predicting rehospitalization and poor quality of life (QOL) in patients with reduced or mid-range ejection fraction heart failure.
Methods From 2009 to 2012, 310 patients were admitted having signs and symptoms of heart failure with reduced ejection fraction.
All the patients were followed by phone, calling the patients or the referring general practitioner.
The Minnesota Living with Heart Failure Questionnaire (MLHFQ) was used as the instrument to evaluate QOL: MLHFQ less than 24 is a good QOL, 24–45 is moderate QOL and more than 45 is poor QOL.
The primary event was poor QOL and/or rehospitalization at 4 years.
Results Seventy-nine patients died at median time of 21 months; 4-year survival was 72 ± 3%.
Rehospitalization due to heart failure was recorded in 60 cases.
Among 231 survivors, MLHFQ score was good in 99 (42%), moderate in 50 (21%) and poor in 88 (37%).
Four-year freedom from death, poor QOL or rehospitalization was 51 ± 3%.
Multivariable analysis identified the following risk factors: heart rate at discharge at least 70 bpm, ischemic heart disease, atrial fibrillation, hypercholesterolemia, chronic pulmonary disease, N-terminal pro brain natriuretic peptide at discharge, severe tricuspid regurgitation and mitral regurgitation more than moderate.
Conclusion Clinical, laboratory and echocardiographic profile is crucial to predict long-term QOL of patients admitted for heart failure.

Related Results

Postoperative rehospitalization in older surgical patients: an age-stratified analysis
Postoperative rehospitalization in older surgical patients: an age-stratified analysis
Abstract Background Older adults comprise 40% of surgical inpatients and are at increased risk of postoperative rehospitalization. A decade ago, 30...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Abstract Background Women with heart disease undergoing pregnancy is on the increase, along with an increasing cardiac contribut...
Medication Adherence, Quality of Life, and Rehospitalization in Post-Acute Coronary Syndrome Patients
Medication Adherence, Quality of Life, and Rehospitalization in Post-Acute Coronary Syndrome Patients
Background: Post-ACS patients often face an increased likelihood of mortality, rehospitalization, and diminished quality of life as a consequence of poor medication adherence. Obje...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Effect of Levosimendan on the short-term clinical efficacy of patients with acute decompensated heart failure
Effect of Levosimendan on the short-term clinical efficacy of patients with acute decompensated heart failure
OBJECTIVE To observe the effect of levosimendan on the clinical efficacy of patients with acute decompensated heart failure (ADHF). METHODS Collected 124 patients with acute decom...
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Empagliflozin in the Real World: Strengthening Heart Failure Care in Pakistan
Heart failure with reduced ejection fraction (HFrEF) remains a major clinical challenge worldwide and is a pressing public health issue in Pakistan. Patients here often present at ...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...

Back to Top